HPLC-CAD-based Oligosaccharides Analysis Service
Overview
Anomalous intercellular sugar chains have been linked to numerous diseases, including cancer and rheumatism. The development of highly sensitive detection methods for sugar chains is therefore essential for advancing biological and pathological studies. CD BioGlyco offers a state-of-the-art high-performance liquid chromatography with charged aerosol detection (HPLC-CAD) based service for the direct and highly sensitive analysis of oligosaccharides. This novel strategy overcomes traditional limitations, delivering a robust and reliable solution across diverse R&D applications.
Key Technologies
HPLC-CAD is a sophisticated detection method that operates on the principle of nebulizing the column eluent with nitrogen gas, evaporating the mobile phase, and then charging the resulting dried particles by impacting them with positively charged nitrogen cations. The amount of electric charge on the eluent is then measured, providing a universal detection mechanism for compounds, even those lacking chromophores or ultraviolet (UV) absorbance.
Oligosaccharides Unlocked: HPLC-CAD Precision Revealed
We offer comprehensive capabilities for the detection and quantification of various oligosaccharides. Our service is particularly adept at the direct detection of underivatized oligosaccharides, eliminating the need for time-consuming and complicated fluorescent derivatization steps often associated with traditional methods. We are equipped to analyze sialylglycopeptides (SGPs) and their hydrolysis products, including monosialo- and asialo-oligosaccharides, as well as free sialic acid. Our capabilities extend to comparing detection sensitivities across different methods (CAD, UV absorbance, and fluorescence detection). The versatility of our HILIC-CAD system, employing amido-silica columns, allows for the effective separation and analysis of a wide range of oligosaccharides. This service is ideal for projects requiring highly sensitive detection and characterization of sugar chains without the drawbacks of conventional derivatization techniques.
Workflow
Our analysis service follows a streamlined and rigorous workflow to ensure accurate and reliable results:
Sample Reception and Assessment
Upon receipt, samples undergo initial quality assessment to confirm suitability for analysis. This includes evaluating sample integrity, concentration, and any specific client requirements.
Method Development and Optimization
Our expert team designs and optimizes the HPLC-CAD method specifically for your oligosaccharide samples. This involves selecting appropriate columns, mobile phases, and detection parameters to achieve optimal separation and sensitivity. Modifiers like trifluoroacetic acid (TFA) are carefully incorporated to improve peak shapes and enhance sensitivity by decreasing background current.
Sample Preparation and Injection
Samples are meticulously prepared according to the optimized method, including any necessary dilutions or filtrations. A fixed injection volume is used for consistent analysis.
HPLC-CAD Analysis
The prepared samples are then analyzed using our HPLC-CAD system. This step involves precise control of flow rates and column temperature to ensure robust separation and detection.
Data Acquisition and Processing
Chromatographic data, including peak areas and heights, are acquired and processed using advanced integration software. Calibration curves are constructed using authentic standards to ensure linearity and accurate quantification.
Interpretation and Reporting
Our scientists interpret the acquired data, identifying and quantifying oligosaccharides. This may include identifying hydrolysis products, such as monosialo- and asialo-oligosaccharides, and free sialic acid. A comprehensive report is then generated, detailing the findings.

Publication Data
Journal: Scientific Reports
IF: 3.8
DOI: 10.1038/s41598-023-37832-4
Published: 2023
Results: This study developed a novel, universal UHPLC-CAD platform, termed UniQS, for directly quantifying and characterizing intact polysaccharide antigens used in glycoconjugate vaccines (e.g., against Streptococcus pneumoniae, Neisseria meningitidis, Staphylococcus aureus). Recognizing the limitations of traditional methods that require specific hydrolysis to monosaccharides and tailored development for each PS serotype, the authors created two complementary ultra-high performance liquid chromatography (UHPLC) methods: a reversed-phase (RP) method (UniQS-1) for neutral and carboxylic acid-containing polysaccharides, and a hydrophilic interaction chromatography (HILIC) method (UniQS-2) specifically for charged/phosphodiester-containing polysaccharides. This platform enables the direct analysis of underivatized polysaccharides without complex derivatization or serotype-specific hydrolysis steps, allows quantification throughout the vaccine production process (from crude fermentation broth to purified polysaccharide), and demonstrates good linearity. The UniQS approach offers significant advantages in speed, cost, and applicability for developing multivalent vaccines by providing a universal analytical strategy for diverse polysaccharide antigens.
Associated Services
Precision characterization of oligosaccharides via HPLC-CAD analysis is the essential first step toward understanding their structure and function. This rigorous analytical foundation now propels the next frontier: sophisticated library construction. Building upon the insights gained from HPLC-CAD profiling, we offer tailored synthesis solutions to generate bespoke oligosaccharide collections:
| Modular Synthesis-based Oligosaccharide Library Construction Service | Enzymatic Synthesis-based Oligosaccharide Library Construction Service | Chemical Synthesis-based Oligosaccharide Library Construction Service |
![]() |
![]() |
![]() |
| For rapid, combinatorial assembly of diverse glycans using pre-validated building blocks. | Leveraging nature's precision for stereospecific, biologically relevant structures. | Enabling access to rare, non-natural analogs through advanced glycosylation strategies. |
Applications
- Our analysis service is useful for identifying potential oligosaccharide biomarkers for disease diagnosis, prognosis, and monitoring.
- Our analysis service can be used to analyze oligosaccharides in food products, providing insights into their nutritional value, prebiotic properties, and potential health benefits.
- Our analysis service is applied to evaluate the success of glycan engineering efforts or to study the pathways and enzymes involved in oligosaccharide biosynthesis.
Advantages
- Our method enables the direct detection of oligosaccharides without requiring complex and time-consuming fluorescent derivatization.
- Our service allows for the detection of compounds that do not absorb UV light, offering a universal detection capability.
- Our strategy is highly effective for analyzing acid hydrolysis products of oligosaccharides, allowing for the detection of monosialo- and asialo-oligosaccharides, as well as free sialic acid.
Frequently Asked Questions
CD BioGlyco is committed to providing unparalleled scientific expertise and cutting-edge analytical solutions for your oligosaccharide analysis and Oligosaccharide Synthesis needs. Our HPLC-CAD-based service is a testament to our dedication to innovation and quality, offering a powerful tool for advancing your research. For detailed information, project consultations, or to request a quote, please do not hesitate to contact our expert team.
Reference
- Corrado, A.; et al. A universal UHPLC-CAD platform for the quantification of polysaccharide antigens. Scientific Reports. 2023, 13(1): 10646. (Open Access)
- Glyco™ Synthesis Platform
- Custom Glycoprotein Synthesis
- Custom Glycoside Synthesis
- Custom Glycosyl Donor Synthesis
- Custom Thioglycoside Synthesis
- Custom Phosphatidylinositol Synthesis
- Custom Cyclodextrin Synthesis
- Custom Rhamnolipid Synthesis
- Custom Sphingolipid Synthesis
- Custom Building Block Synthesis
- Carbohydrate Manufacturing
- Synthesis Process Development and Optimization
- Custom Carbohydrate Synthesis
- Custom Glycolipid Synthesis
- Custom Glycopeptide Synthesis
- Custom Glycoconjugate Synthesis
- Custom Sugar-Nucleotide Synthesis
- Nucleoside & Nucleotide Synthesis Service
- Custom Oligonucleotide Synthesis Service
- Polynucleotide Synthesis Service
- Nucleoside & Nucleotide Modification Service
- Oligonucleotide Modification Service
- Nucleoside-based Production Service
- Nucleotide-based Production Service
- OPME-based NDP-sugar Synthesis Service
- OPME-based NMP-sugar Synthesis Service
- Glycomics Platform
- Glycoproteomics Platform
- N-Glycoproteomics of PDX Models
- Nanotechnologies for the Detection of Glycopeptides
- Glycoprotein Enrichment
- Glycoprotein Quantification
- Glyco-biomarker Detection Service
- Glyco-biomarker AFP Detection Service
- Glyco-biomarker CA19-9 Detection Service
- Glyco-biomarker CA125 Detection Service
- Glyco-biomarker CA15–3 Detection Service
- Glyco-biomarker CEA Detection Service
- Glyco-biomarker PSA Detection Service
- Glyco-biomarker Immunoglobulin G (IgG) Detection Service
- Glyco-biomarker Haptoglobin (Hp) Detection Service
- Glyco-biomarker α1-Antitrypsin (A1AT) Detection Service
- Glyco-biomarker α1-Acid Glycoprotein (AGP) Detection Service
- Glyco-biomarker Ceruloplasmin (CP) Detection Service
- Glyco-biomarker Fetuin A Detection Service
- Site Occupation
- Glycoprotein Structure Analysis
- Glycosylation Site-specific Antibody-Drug Conjugate (ADC) Development Platform
- Carbohydrate-based Glycomedicine Development Platform
- By Sources of Carbohydrate
- By Types of Carbohydrate
- Monosaccharides-based Glycomedicine Development
- Disaccharides-based Glycomedicine Development
- Trisaccharides-based Glycomedicine Development
- Oligosaccharides-based Glycomedicine Development
- Polysaccharides-based Glycomedicine Development
- Glycosides-based Glycomedicine Development
- Glycopeptide-based Glycomedicine Development
- Glycomimetic-based Glycomedicine Development
- By Applications of-based Glycomedicines
- Carbohydrate-based Anticoagulant Glycomedicine Development
- Carbohydrate-based Cardiovascular Glycomedicine Development
- Carbohydrate-based Antitumor Glycomedicine Development
- Carbohydrate-based Antidiabetic Glycomedicine Development
- Carbohydrate-based Antibacterial Glycomedicine Development
- Carbohydrate-based Antiviral Glycomedicines Development
- Carbohydrate-based Antiparasiti Glycomedicine Development
- By Discovery Strategies
- Glycoengineering-based Glycomedicine Development
- Production of Food Ingredients
- Multi-omics Platform for Cancer Glucose Metabolism (MOPCGM)
- Cancer Cell Glycolytic Analysis
- Cancer Cell TCA Cycle Analysis
- Cancer Cell PPP Analysis
- Gene-level Regulation Analysis of Cancer Glucose Metabolism
- Interplay Between Glucose Metabolism Reprogramming and Tumorigenesis & Progression
- Interplay Between Glucose Metabolism Reprogramming and Proliferative Signaling
- Interplay Between Glucose Metabolism Reprogramming and Growth Suppressor
- Interplay Between Glucose Metabolism Reprogramming and Cancer Cell Death
- Interplay Between Glucose Metabolism Reprogramming and Replicative Immortality
- Interplay Between Glucose Metabolism Reprogramming and Angiogenesis
- Interplay Between Glucose Metabolism Reprogramming and Invasion & Metastasis
- Interplay Between Glucose Metabolism Reprogramming and Immune Escape
- Interplay Between Glucose Metabolism Reprogramming and Genomic Instability
- Interplay Between Glucose Metabolism Reprogramming and Tumor-associated Inflammation
- Glucose Metabolism-Microenvironment Crosstalk Analysis in Cancer
- Cancer Glucose Metabolism In Vivo Analysis
- Applications of Studing Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism Small Molecule Inhibitor
- Discovery of Cancer Glucose Metabolism Therapeutic Monoclonal Antibodies
- Development of Gene Therapy Targeting Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism CAR-T Therapy Targeting
- Discovery of Cancer Glucose Metabolism Combination Therapy Strategy
- Discovery of Cancer Glucose Metabolism Precision Therapeutic Strategies
- Glycoengineering Platform
- Therapeutic Nucleic Acid Development Platform
- Therapeutic Oligonucleotide Synthesis Service
- siRNA Synthesis
- miRNA Synthesis
- ASO Synthesis
- Aptamer Synthesis
- PMO Synthesis
- sgRNA Synthesis
- Circular RNA Synthesis
- PNA Synthesis
- Lipid-based GalNac-RNA Delivery Service
- CpG Oligonucleotide Synthesis
- Click-based GalNac-RNA Delivery Service
- AntimiR Synthesis
- GalNAc-siRNA Delivery Service
- tRNA Synthesis
- GalNAc-ASO Delivery Service
- saRNA Synthesis
- Reporter Gene mRNA Synthesis
- Gene Editing mRNA Synthesis
- Gene Replacement mRNA Synthesis
- Cre Recombinase mRNA Synthesis
- hEPO mRNA Synthesis
- OVA mRNA Synthesis
- Therapeutic Oligonucleotide Modification Service
- Therapeutic Oligonucleotide Delivery Development Service
- Targeted Ligand and Linker Synthesis
- Monoantennary GalNac-RNA Delivery
- Biantennary GalNac-RNA Delivery
- Triantennary GalNac-RNA Delivery
- Tetra-antennary GalNac-RNA Delivery
- Solution Phase-based GalNac-RNA Delivery
- Solid Phase-based GalNac-RNA Delivery
- mRNA Poly(A) Tail Length Analysis
- GalNAc-siRNA Delivery
- GalNAc-ASO Delivery
- GalNAc-miRNA Delivery
- GalNAc-Aptamer Delivery
- GalNAc-AntimiR Delivery
- GalNAc-mRNA Delivery
- GalNAc-PNA Delivery
- Peptide-Therapeutic Oligonucleotide Delivery
- LNP-Therapeutic Oligonucleotide Delivery
- PEG-Therapeutic Oligonucleotide Delivery
- Biological Evaluation Service for Therapeutic Oligonucleotide
- mRNA-based Vaccine Development Service
- mRNA Sequence Design&Optimization Service
- mRNA Integrity Analysis ServicemRNA Integrity Analysis Service
- mRNA Biodistribution Analysis Service
- DNA Template Preparation Service
- mRNA Purity Analysis Service
- T Cell Cytokine Secretion Analysis Service
- mRNA Modification Service
- mRNA Length Analysis Service
- mRNA Purification Service
- Neutralizing Antibody Assay Service
- mRNA-LNP Formulation and Encapsulation Service
- mRNA Structural Characterization
- mRNA Structural Characterization Service
- mRNA Bioanalysis Service
- mRNA Residual DNA Template Analysis Service
- mRNA Residual Double-Stranded RNA (dsRNA) Analysis Service
- mRNA Size Analysis Service
- mRNA Polydispersity Analysis Service
- mRNA Zeta Potential Analysis Service
- mRNA Lipid Composition Analysis Service
- Oligonucleotide Drug Process and Formulation Development Service
- RNA Drug Process and Formulation Development
- Therapeutic Oligonucleotide Synthesis Service
- Glycobiology Microarray Platform
- Glyco™ Vaccine Development Platform
- Carbohydrate-based Vaccine Development
- Polysaccharide Vaccine Development
- Tumor-Associated Carbohydrate Vaccine Development
- Glycoconjugate Vaccine Development
- Natural Carbohydrate-based Vaccine Development
- Semi-synthetic Carbohydrate-based Vaccine Development
- Fully Synthetic Carbohydrate-based Vaccine Development
- Carbohydrate-based Antibacterial Vaccine Development
- Carbohydrate-based Antifungal Vaccine Development
- Carbohydrate-based Antiparasitic Vaccine Development
- Carbohydrate-based Antiviral Vaccine Development
- Carbohydrate-based Anticancer Vaccine Development
- Carbohydrate-based Antihelmintic Vaccine Development
- Monovalent Carbohydrate-based Vaccine Development
- Polyvalent Carbohydrate-based Vaccine Development
- Carrier Protein Design Service
- Carbohydrate Conjugation Service for Vaccine Development
- Carbohydrate-based Adjuvant Development
- Lipopolysaccharide-based Adjuvant Development
- Bacterial Outer Membrane Vesicles (OMVs)-based Adjuvant Development
- Trehalose Glycolipid-based Adjuvant Development
- Galactosylceramide-based Adjuvant Development
- Peptidoglycan-based Adjuvant Development
- Chitin/Chitosan-based Adjuvant Development
- Inulin-based Adjuvant Development
- Mannans-based Adjuvant Development
- Alginate-based Adjuvant Development
- Saponin-based Adjuvant Development
- α-Glucan-based Adjuvant Development
- Lentinan-based Adjuvant Development
- β-Glucans-based Adjuvant Development
- Deltin-based Adjuvant Development
- Muramyldipeptide-based Adjuvant Development
- Cord Factor-based Adjuvant Development
- Zwitterionic Polysaccharide-based Adjuvant Development
- Novel Plant Polysaccharides-based Adjuvant Development
- Glycoprotein-based Vaccine Development
- Glycopeptide-based Vaccine Development
- Carbohydrate-based Vaccine Development
- Glycogenomics Platform
- Glycogene Editing Service
- Glycogene Delivery Service
- Glycogene Expression Profiling
- Cancer Glycogene Discovery Service
- Glycogene Discovery Service in Cervical Cancer
- Glycogene Discovery Service in Leukemia
- Glycogene Discovery Service in Bladder Cancer
- Glycogene Discovery Service in Colorectal Adenocarcinoma
- Glycogene Discovery Service in Liver Cancer
- Glycogene Discovery Service in Lymphoma
- Glycogene Discovery Service in Breast Cancer
- Glycogene Discovery Service in Prostate Cancer
- Glycogene Discovery Service in Pancreatic Cancer
- Glycogene Discovery Service in Lung Cancer
- Glycogene Discovery Service in Thyroid Cancer
- Glycogene Discovery Service in Ovarian Cancer
- Glycan Display Platform
- Traditional Glycan Display Array
- Natural Oligosaccharide Library Construction Service
- Chemical Synthesis-based Oligosaccharide Library Construction Service
- Enzymatic Synthesis-based Oligosaccharide Library Construction Service
- Modular Synthesis-based Oligosaccharide Library Construction Service
- Oligosaccharide Library Immobilization Service
- Cell-based Glycan Display Array
- Neoglycolipid (NGL) Display Array
- Liquid Glycan Display Array (LiGA)
- Glycophage Display
- N-linked Glycoprotein-based Glycophage Display System Construction Service
- O-linked Glycoprotein-based Glycophage Display System Construction Service
- Glycophage Display-based Glycosylase Genetic Analysis Service
- Glycophag Display-based Glycoarray Service
- Glycophage Display-based Antibody Development Service
- Glycophage Display-based Epitope Mapping Service
- Glycophage Display-based Biomarker Development Service
- De Novo Glycan Display
- Cell-Surface Glycan Editing
- Examining the Effects of Altering Blood Group Antigens on Erythrocyte Cell Surfaces
- Preventing Cellular Rejection During Transplantation
- Modulating Chemical Composition and Physical Parameters of Glycocalyx
- Tailoring Cell Membranes with Biologically Active Glycans
- Targeting Glycosaminoglycan-mediated Growth Factor Signaling to Influence Stem Cell Specification
- Long-term De Novo Glycan Display for Directing Stem Cell Fate
- Traditional Glycan Display Array
- GlycoNano™ Platform
- Glyconanoparticle Development Service
- Techniques for Glyconanoparticle Development
- Carbohydrate-based Nanoparticle Production
- Gold Glyconanoparticle Production
- Silver Glyconanoparticle
- Magnetic Glyconanoparticle
- Quantum Dot (QD) Glyconanoparticle
- Glyconanoparticle Characterization
- PEG Glyconanoparticle
- Carbon-based Glyconanoparticle
- Fluorescent Glyconanoparticle
- Silica Glyconanoparticle
- Liposome Glyconanoparticle
- Glycol Nanohydrogel Development
- Glycol Nanorod
- Glycol Nanotube
- Glycol Nanocrystal/Nanosheet/Nanosphere/Nanofiber
- Glyconanoparticle Preclinical Study
- Glyconanoparticle Formulation
- Glyconanotechnology-based Biosensor Development
- GlycoNano™ Bioink Production for 3D Printing
- Glyconanoparticle Development Service
- Glyco™ Synthesis Platform


